1 in 3 with GvHD. Industry average has been quoted a 50/50 once at Phase 3, and given small sample size MSB is probably in the ballpark.
Ann: FDAs OTAT Agrees to Primary Endpoint for Back Pain, page-126
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.45 |
Change
-0.020(1.37%) |
Mkt cap ! $1.672B | |||
| Open | High | Low | Value | Volume |
| $1.45 | $1.46 | $1.44 | $579.0K | 399.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 19478 | $1.44 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.45 | 3271 | 3 |
View Market Depth
| Last trade - 10.14am 09/10/2024 (20 minute delay) ? |
| MSB (ASX) Chart |